CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Shares withheld for taxes President and CEO gave up 139,524 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Research and Development gave up 27,254 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 32,332 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 40,459 shares (to pay taxes)
- 4 Grant or award SVP and General Counsel acquired 30,170 shares (grant or award)
- 4 Open-market buy Director bought 27,532 shares at $43.12 ($1,187,235)
- 4 Open-market sale EVP, Commercial sold 72,230 shares at an average $42.18 ($3,046,928)
- 4 Gift EVP, Research and Development gave 24,000 shares (gift)
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 1,044 shares (gift)
- 4 Open-market sale Director sold 100,000 shares at $43.55 ($4,355,000)
- 4 Gift President and CEO gave 341,548 shares (gift)
- 4 Open-market sale EVP, Research and Development sold 48,383 shares at $42.50 ($2,056,278)
- 4 Open-market sale Director sold 24,622 shares at an average $41.93 ($1,032,414)
- 4 Grant or award EVP, Research & Development acquired 50,673 shares (grant or award)
- 4 Planned sale Director sold 18,838 shares at an average $42.74 ($805,140)
- 4 Planned sale Director sold 7,535 shares at $43.09 ($324,683)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 9,812 shares (grant or award)
- 4 Grant or award Director acquired 9,812 shares (grant or award)
Page 3 of 73 · 1,458 filings